Task: Answer the multiple-choice question.
Question: Which compound exhibits a 3.072% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CC1CCN(CCNC(=O)c2ccc(NC(=O)C3CCCO3)cc2)CC1
[b] O=C(NC1CCCN(Cc2ccccc2F)C1)c1cccs1
[c] CC1(C)Cc2nc3sc(C(=O)NCCCO)c(N)c3cc2CS1
Answer: a. CC1CCN(CCNC(=O)c2ccc(NC(=O)C3CCCO3)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(CCNC(=O)c2ccc(NC(=O)C3CCCO3)cc2)CC1
CC1CCN(CCNC(=O)c2ccc(NC(=O)C3CCCO3)cc2)CC1
N-[4-[2-(4-methylpiperidin-1-yl)ethylcarbamoyl]phenyl]oxolane-2-carboxamide